KeyBank National Association’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.8M | Buy |
1,445,780
+25,946
| +2% | +$679K | 0.11% | 135 |
|
|
2026
Q1 | $39.9M | Buy |
1,419,834
+10,655
| +0.8% | +$284K | 0.15% | 120 |
|
|
2025
Q4 | $35.1M | Buy |
1,409,179
+58,642
| +4% | +$1.48M | 0.13% | 128 |
|
|
2025
Q3 | $34.4M | Sell |
1,350,537
-37,883
| -3% | -$935K | 0.12% | 130 |
|
|
2025
Q2 | $33.7M | Sell |
1,388,420
-156,344
| -10% | -$3.65M | 0.13% | 132 |
|
|
2025
Q1 | $39.1M | Sell |
1,544,764
-65,153
| -4% | -$1.7M | 0.16% | 116 |
|
|
2024
Q4 | $42.7M | Sell |
1,609,917
-75,877
| -5% | -$2.06M | 0.16% | 114 |
|
|
2024
Q3 | $48.8M | Sell |
1,685,794
-175,440
| -9% | -$5.12M | 0.19% | 104 |
|
|
2024
Q2 | $52.1M | Sell |
1,861,234
-146,024
| -7% | -$4.02M | 0.21% | 100 |
|
|
2024
Q1 | $55.7M | Sell |
2,007,258
-176,695
| -8% | -$4.9M | 0.23% | 93 |
|
|
2023
Q4 | $62.9M | Sell |
2,183,953
-131,282
| -6% | -$3.97M | 0.28% | 76 |
|
|
2023
Q3 | $76.8M | Sell |
2,315,235
-78,621
| -3% | -$2.78M | 0.37% | 66 |
|
|
2023
Q2 | $87.8M | Sell |
2,393,856
-128,011
| -5% | -$4.98M | 0.4% | 62 |
|
|
2023
Q1 | $103M | Sell |
2,521,867
-131,854
| -5% | -$5.69M | 0.49% | 54 |
|
|
2022
Q4 | $136M | Sell |
2,653,721
-41,391
| -2% | -$1.98M | 0.67% | 36 |
|
|
2022
Q3 | $118M | Sell |
2,695,112
-20,929
| -0.8% | -$1.02M | 0.61% | 35 |
|
|
2022
Q2 | $142M | Sell |
2,716,041
-42,486
| -2% | -$2.17M | 0.7% | 30 |
|
|
2022
Q1 | $143M | Sell |
2,758,527
-54,162
| -2% | -$2.81M | 0.6% | 39 |
|
|
2021
Q4 | $166M | Sell |
2,812,689
-27,502
| -1% | -$1.36M | 0.66% | 34 |
|
|
2021
Q3 | $122M | Sell |
2,840,191
-35,419
| -1% | -$1.57M | 0.53% | 46 |
|
|
2021
Q2 | $113M | Sell |
2,875,610
-84,614
| -3% | -$3.29M | 0.49% | 46 |
|
|
2021
Q1 | $107M | Sell |
2,960,224
-129,548
| -4% | -$4.6M | 0.5% | 48 |
|
|
2020
Q4 | $114M | Sell |
3,089,772
-318,474
| -9% | -$11.7M | 0.56% | 42 |
|
|
2020
Q3 | $119M | Sell |
3,408,246
-173,327
| -5% | -$6.08M | 0.64% | 37 |
|
|
2020
Q2 | $111M | Sell |
3,581,573
-184,762
| -5% | -$6.28M | 0.64% | 37 |
|
|
2020
Q1 | $117M | Sell |
3,766,335
-287,096
| -7% | -$9.78M | 0.78% | 24 |
|
|
2019
Q4 | $151M | Sell |
4,053,431
-553,694
| -12% | -$19.7M | 0.81% | 23 |
|
|
2019
Q3 | $157M | Sell |
4,607,125
-37,220
| -0.8% | -$1.35M | 0.9% | 23 |
|
|
2019
Q2 | $191M | Buy |
4,644,345
+14,462
| +0.3% | +$574K | 1.11% | 17 |
|
|
2019
Q1 | $187M | Buy |
4,629,883
+27,793
| +0.6% | +$1.11M | 1.11% | 16 |
|
|
2018
Q4 | $191M | Sell |
4,602,090
-4,266
| -0.1% | -$177K | 1.25% | 14 |
|
|
2018
Q3 | $193M | Buy |
4,606,356
+1,279
| +0% | +$49.2K | 1.07% | 17 |
|
|
2018
Q2 | $159M | Buy |
4,605,077
+178,142
| +4% | +$6.09M | 0.92% | 21 |
|
|
2018
Q1 | $149M | Buy |
4,426,935
+148,229
| +3% | +$5.1M | 0.88% | 22 |
|
|
2017
Q4 | $147M | Sell |
4,278,706
-112,332
| -3% | -$3.83M | 0.84% | 23 |
|
|
2017
Q3 | $149M | Sell |
4,391,038
-47,035
| -1% | -$1.51M | 0.88% | 22 |
|
|
2017
Q2 | $141M | Sell |
4,438,073
-81,488
| -2% | -$2.57M | 0.85% | 22 |
|
|
2017
Q1 | $147M | Sell |
4,519,561
-58,324
| -1% | -$1.84M | 0.88% | 22 |
|
|
2016
Q4 | $141M | Sell |
4,577,885
-95,976
| -2% | -$2.93M | 0.88% | 23 |
|
|
2016
Q3 | $150M | Buy |
4,673,861
+25,277
| +0.5% | +$845K | 0.94% | 21 |
|
|
2016
Q2 | $155M | Buy |
4,648,584
+10,671
| +0.2% | +$341K | 1.01% | 17 |
|
|
2016
Q1 | $130M | Sell |
4,637,913
-62,474
| -1% | -$1.78M | 0.87% | 23 |
|
|
2015
Q4 | $144M | Sell |
4,700,387
-88,592
| -2% | -$2.79M | 0.97% | 21 |
|
|
2015
Q3 | $143M | Sell |
4,788,979
-69,608
| -1% | -$2.23M | 1.01% | 21 |
|
|
2015
Q2 | $155M | Sell |
4,858,587
-111,156
| -2% | -$3.62M | 1.03% | 18 |
|
|
2015
Q1 | $164M | Sell |
4,969,743
-24,049
| -0.5% | -$765K | 1.07% | 15 |
|
|
2014
Q4 | $148M | Sell |
4,993,792
-31,082
| -0.6% | -$891K | 0.97% | 20 |
|
|
2014
Q3 | $141M | Sell |
5,024,874
-66,868
| -1% | -$1.88M | 0.97% | 20 |
|
|
2014
Q2 | $143M | Sell |
5,091,742
-16,688
| -0.3% | -$476K | 0.95% | 21 |
|
|
2014
Q1 | $156M | Sell |
5,108,430
-37,182
| -0.7% | -$1.11M | 1.2% | 15 |
|
|
2013
Q4 | $150M | Sell |
5,145,612
-59,475
| -1% | -$1.73M | 0.98% | 21 |
|
|
2013
Q3 | $142M | Sell |
5,205,087
-6,227,632
| -54% | -$169M | 0.98% | 19 |
|
|
2013
Q2 | $304M | Buy |
+11,432,719
| New | +$316M | 1.12% | 8 |
|
Other funds holding PFE
KeyBank National Association's PFE Position: Q2 2026 in Review
KeyBank National Association increased its Pfizer (PFE) stake by 1.8% in Q2 2026, buying an estimated $679K and bringing the position to 1,445,780 shares worth $34.8M. The position accounts for 0.11% of the portfolio, ranked #135.
KeyBank National Association first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $304M in Q2 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- KeyBank National Association held 1,445,780 shares of Pfizer worth $34.8M as of Q2 2026.
- KeyBank National Association bought 25,946 Pfizer shares in Q2 2026, an estimated $679K.
- Pfizer made up 0.11% of KeyBank National Association's portfolio in Q2 2026, its #135 holding.
- KeyBank National Association first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Pfizer position peaked at $304M in Q2 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.